Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

Imagem de Miniatura
Arquivos
art_HALLIDAY_Second_asymptomatic_carotid_surgery_trial_ACST2_a_randomised_2021.PDF (868.45 KB)
Citações na Scopus
129
Tipo de produção
article
Data de publicação
2021
DOI
Scopus
Web of Science
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
HALLIDAY, Alison
BULBULIA, Richard
BONATI, Leo H.
CHESTER, Johanna
CRADDUCK-BAMFORD, Andrea
PETO, Richard
PAN, Hongchao
Citação
LANCET, v.398, n.10305, p.1065-1073, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Among asymptomatic patients with severe carotid artery stenosis but no recent stroke or transient cerebral ischaemia, either carotid artery stenting (CAS) or carotid endarterectomy (CEA) can restore patency and reduce long-term stroke risks. However, from recent national registry data, each option causes about 1% procedural risk of disabling stroke or death. Comparison of their long-term protective effects requires large-scale randomised evidence. Methods ACST-2 is an international multicentre randomised trial of CAS versus CEA among asymptomatic patients with severe stenosis thought to require intervention, interpreted with all other relevant trials. Patients were eligible if they had severe unilateral or bilateral carotid artery stenosis and both doctor and patient agreed that a carotid procedure should be undertaken, but they were substantially uncertain which one to choose. Patients were randomly allocated to CAS or CEA and followed up at 1 month and then annually, for a mean 5 years. Procedural events were those within 30 days of the intervention. Intention-to-treat analyses are provided. Analyses including procedural hazards use tabular methods. Analyses and meta-analyses of non-procedural strokes use Kaplan-Meier and log-rank methods. The trial is registered with the ISRCTN registry, ISRCTN21144362. Findings Between Jan 15, 2008, and Dec 31, 2020, 3625 patients in 130 centres were randomly allocated, 1811 to CAS and 1814 to CEA, with good compliance, good medical therapy and a mean 5 years of follow- up. Overall, 1% had disabling stroke or death procedurally (15 allocated to CAS and 18 to CEA) and 2% had non-disabling procedural stroke (48 allocated to CAS and 29 to CEA). Kaplan-Meier estimates of 5-year non-procedural stroke were 2. 5% in each group for fatal or disabling stroke, and 5.3% with CAS versus 4.5% with CEA for any stroke (rate ratio [RR] 1.16, 95% CI 0.86-1.57; p=0 .33). Combining RRs for any non-procedural stroke in all CAS versus CEA trials, the RR was similar in symptomatic and asymptomatic patients (overall RR 1.11, 95% CI 0.91-1.32; p=0.21). Interpretation Serious complications are similarly uncommon after competent CAS and CEA, and the long-term effects of these two carotid artery procedures on fatal or disabling stroke are comparable.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/50364
Referências
  1. Bonati LH, 2015, LANCET, V385, P529, DOI 10.1016/S0140-6736(14)61184-3
  2. Brott TG, 2019, LANCET NEUROL, V18, P348, DOI 10.1016/S1474-4422(19)30028-6
  3. Brott TG, 2016, NEW ENGL J MED, V374, P1021, DOI 10.1056/NEJMoa1505215
  4. Chambers BR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001923.pub2
  5. Cole TS, 2020, STROKE, V51, P579, DOI 10.1161/STROKEAHA.119.027388
  6. Collins R, 2020, NEW ENGL J MED, V382, P674, DOI 10.1056/NEJMsb1901642
  7. Eckstein HH, 2008, LANCET NEUROL, V7, P893, DOI 10.1016/S1474-4422(08)70196-0
  8. Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X
  9. Hills Robert K, 2009, J Evid Based Med, V2, P196, DOI 10.1111/j.1756-5391.2009.01023.x
  10. Institut fur Qualitatssicherung und Transparenz im Gesundheitswesen (IQTiG), KAR REV
  11. Mas JL, 2008, LANCET NEUROL, V7, P885, DOI 10.1016/S1474-4422(08)70195-9
  12. Muller MD, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000515.pub5, 10.1161/STROKEAHA.120.030521]
  13. Peto R, CAROTID ARTERY SURG
  14. Reiff T, 2020, INT J STROKE, V15, P638, DOI 10.1177/1747493019833017
  15. Rosenfield K, 2016, NEW ENGL J MED, V374, P1011, DOI 10.1056/NEJMoa1515706
  16. Schmid S, 2017, J AM HEART ASSOC, DOI 10.1161/JAHA.116.004764
  17. Venermo M, 2017, EUR J VASC ENDOVASC, V53, P511, DOI 10.1016/j.ejvs.2017.01.012
  18. Zannetti S, 1998, EUR J VASC ENDOVASC, V15, P528, DOI 10.1016/S1078-5884(98)80114-7

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/02
Artigos e Materiais de Revistas Científicas - ODS/03